{"id":"https://openalex.org/W2168029948","doi":"https://doi.org/10.1158/1078-0432.ccr-08-1144","title":"Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma","display_name":"Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma","publication_year":2008,"publication_date":"2008-12-01","ids":{"openalex":"https://openalex.org/W2168029948","doi":"https://doi.org/10.1158/1078-0432.ccr-08-1144","mag":"2168029948","pmid":"https://pubmed.ncbi.nlm.nih.gov/19047099"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-08-1144","doi":"https://doi.org/10.1158/1078-0432.ccr-08-1144","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-1144","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/14/23/7726/1980019/7726.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/14/23/7726/1980019/7726.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061257236","display_name":"Xiaofeng Jiang","orcid":"https://orcid.org/0000-0002-5483-8111","observed_orcids":["https://orcid.org/0000-0002-5483-8111"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaofeng Jiang","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","4Melanoma Program and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Melanoma Program and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101813423","display_name":"Jun Zhou","orcid":"https://orcid.org/0000-0002-4449-4458","observed_orcids":["https://orcid.org/0000-0002-4449-4458"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Zhou","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","4Melanoma Program and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Melanoma Program and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034124370","display_name":"Noah K. Yuen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I117965899","display_name":"University of Hawai\u02bbi at M\u0101noa","ror":"https://ror.org/01wspgy28","country_code":"US","type":"education","lineage":["https://openalex.org/I117965899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah K. Yuen","raw_affiliation_strings":["6John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii; and","institution_ids":["https://openalex.org/I117965899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026593581","display_name":"Christopher L. Corless","orcid":"https://orcid.org/0000-0003-4871-8364","observed_orcids":["https://orcid.org/0000-0003-4871-8364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher L. Corless","raw_affiliation_strings":["7Department of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091057405","display_name":"Michael Charles Heinrich","orcid":"https://orcid.org/0000-0003-3790-0478","observed_orcids":["https://orcid.org/0000-0003-3790-0478"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael C. Heinrich","raw_affiliation_strings":["8Division of Hematology and Oncology, Oregon Health & Science University and Portland VA Medical Center, Portland, Oregon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Division of Hematology and Oncology, Oregon Health & Science University and Portland VA Medical Center, Portland, Oregon","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040359760","display_name":"Jonathan Alfred Fletcher","orcid":"https://orcid.org/0000-0002-5109-2588","observed_orcids":["https://orcid.org/0000-0002-5109-2588"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A. Fletcher","raw_affiliation_strings":["2Department of Pathology, Brigham and Women's Hospital, Harvard Medical School;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Pathology, Brigham and Women's Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060580923","display_name":"George D. Demetri","orcid":"https://orcid.org/0000-0002-0045-4809","observed_orcids":["https://orcid.org/0000-0002-0045-4809"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George D. Demetri","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","5Ludwig Center, Dana-Farber Cancer Institute, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"5Ludwig Center, Dana-Farber Cancer Institute, Boston, Massachusetts;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022764850","display_name":"Hans R. Widlund","orcid":"https://orcid.org/0000-0002-7506-2447","observed_orcids":["https://orcid.org/0000-0002-7506-2447"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans R. Widlund","raw_affiliation_strings":["3Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Cutaneous Biology Research Center, Department of Dermatology, Melanoma Program, Massachusetts General Hospital, Harvard Medical School;","4Melanoma Program and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Cutaneous Biology Research Center, Department of Dermatology, Melanoma Program, Massachusetts General Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Melanoma Program and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078874539","display_name":"David E. Fisher","orcid":"https://orcid.org/0000-0002-5506-0575","observed_orcids":["https://orcid.org/0000-0002-5506-0575"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Fisher","raw_affiliation_strings":["3Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Cutaneous Biology Research Center, Department of Dermatology, Melanoma Program, Massachusetts General Hospital, Harvard Medical School;","4Melanoma Program and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Cutaneous Biology Research Center, Department of Dermatology, Melanoma Program, Massachusetts General Hospital, Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Melanoma Program and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084967339","display_name":"Frank Stephen Hodi","orcid":"https://orcid.org/0000-0001-6825-091X","observed_orcids":["https://orcid.org/0000-0001-6825-091X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Stephen Hodi","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","4Melanoma Program and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Melanoma Program and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.2183,"has_fulltext":true,"cited_by_count":132,"citation_normalized_percentile":{"value":0.98305386,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"14","issue":"23","first_page":"7726","last_page":"7732"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.014399999752640724,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.8730000257492065},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.8700000047683716},{"id":"https://openalex.org/keywords/mucosal-melanoma","display_name":"mucosal melanoma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/acral-melanoma","display_name":"acral melanoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7409999966621399},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9750000238418579},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9850000143051147},{"id":"https://openalex.org/keywords/melanoma-cell-proliferation","display_name":"melanoma cell proliferation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/drug-resistance-markers","display_name":"drug resistance markers","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8091983795166016},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7738560438156128},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.7514258623123169},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.670559823513031},{"id":"https://openalex.org/C2781186586","wikidata":"https://www.wikidata.org/wiki/Q6931266","display_name":"Mucosal melanoma","level":3,"score":0.5560469627380371},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5353034138679504},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.46817201375961304},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41520100831985474},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.41487085819244385},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.37396156787872314},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.05930668115615845},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009092","descriptor_name":"Mucous Membrane","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-08-1144","doi":"https://doi.org/10.1158/1078-0432.ccr-08-1144","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-1144","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/14/23/7726/1980019/7726.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:19047099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19047099","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.534.6616","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.534.6616","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.heinrich-corless.net/melanoma_targeting_with_imatinib.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-08-1144","doi":"https://doi.org/10.1158/1078-0432.ccr-08-1144","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-08-1144","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/14/23/7726/1980019/7726.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1715191374","display_name":null,"funder_award_id":"I01 BX000338","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320308296","display_name":"Melanoma Research Alliance","ror":"https://ror.org/025ck6r46"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2168029948.pdf","grobid_xml":"https://content.openalex.org/works/W2168029948.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1487917997","https://openalex.org/W1556120715","https://openalex.org/W1829794674","https://openalex.org/W1987372760","https://openalex.org/W1989121777","https://openalex.org/W1994376203","https://openalex.org/W1995529958","https://openalex.org/W1995930366","https://openalex.org/W2006480057","https://openalex.org/W2015015957","https://openalex.org/W2015682571","https://openalex.org/W2016086822","https://openalex.org/W2018789635","https://openalex.org/W2022165580","https://openalex.org/W2028750359","https://openalex.org/W2031510245","https://openalex.org/W2050509360","https://openalex.org/W2051718122","https://openalex.org/W2063956512","https://openalex.org/W2078682377","https://openalex.org/W2079641245","https://openalex.org/W2084741194","https://openalex.org/W2101214437","https://openalex.org/W2108431450","https://openalex.org/W2114918609","https://openalex.org/W2144200294","https://openalex.org/W2145402938","https://openalex.org/W2150501295","https://openalex.org/W2152764077","https://openalex.org/W2156266404","https://openalex.org/W2161275429","https://openalex.org/W2169363650","https://openalex.org/W2329648702"],"related_works":["https://openalex.org/W7098448692","https://openalex.org/W2747197240","https://openalex.org/W1531075915","https://openalex.org/W2103152130","https://openalex.org/W60508422","https://openalex.org/W2147474070","https://openalex.org/W2073548269","https://openalex.org/W4249250207","https://openalex.org/W2240325451","https://openalex.org/W2085357061"],"abstract_inverted_index":{"PURPOSE:":[0],"Melanoma":[1],"subtypes":[2],"based":[3,15],"on":[4,16,127],"anatomic":[5],"location":[6],"and":[7,22,36,101,113,150,157,172,185,217,248],"UV":[8],"light":[9],"exposure":[10],"can":[11],"be":[12],"further":[13,77],"classified":[14],"genetic":[17],"alterations":[18],"recently":[19,40],"identified.":[20],"Mutations":[21],"gene":[23],"amplification":[24],"in":[25,30,67,82,180,212,228,243],"KIT":[26,51,65,94,143,155,179,196,235],"have":[27],"been":[28],"described":[29],"a":[31,42,49,59,154,183,238],"significant":[32],"percentage":[33],"of":[34,64,80,178,204,227],"mucosal":[35,46],"acral":[37],"melanomas.":[38],"We":[39,73],"reported":[41],"patient":[43],"with":[44,54,142,201],"metastatic":[45],"melanoma":[47,84,89,136,181,205,245],"harboring":[48],"known":[50],"mutation":[52],"treated":[53],"imatinib":[55,81,132,139],"mesylate":[56],"who":[57],"experienced":[58],"major":[60,193],"response.":[61],"Biological":[62],"effects":[63,79,107,126],"inhibition":[66,198,236],"these":[68,83],"melanomas":[69],"remain":[70],"poorly":[71],"understood.":[72],"sought":[74],"to":[75,124,153,162,195],"investigate":[76],"the":[78,165],"subsets.":[85],"EXPERIMENTAL":[86],"DESIGN:":[87],"Mucosal":[88,135],"cells":[90,137],"were":[91,108,119],"analyzed":[92],"for":[93,240,252],"aberrations":[95],"by":[96,110,121,199,234],"genomic":[97],"sequencing,":[98],"quantitative":[99],"PCR,":[100],"single":[102],"nucleotide":[103],"polymorphism":[104],"analyses.":[105],"Imatinib":[106,146],"assayed":[109,120],"viability":[111],"measurements":[112],"apoptotic":[114],"cytotoxicity.":[115],"Tumor":[116],"cell":[117,159,206,246],"lysates":[118],"Western":[122],"blots":[123],"determine":[125],"multiple":[128],"signaling":[129,213],"pathways":[130],"after":[131],"exposure.":[133],"RESULTS:":[134],"exhibited":[138],"sensitivity":[140,194],"correlating":[141],"mutational":[144],"status.":[145],"dramatically":[147],"decreased":[148],"proliferation":[149,216],"was":[151],"cytotoxic":[152],"mutated":[156],"amplified":[158],"culture.":[160],"Exposure":[161],"drug":[163],"affected":[164,233],"mitogen-activated":[166],"protein":[167],"kinase,":[168],"phosphatidylinositol":[169],"3-kinase/AKT,":[170],"JAK-STAT,":[171],"antiapoptotic":[173],"pathways.":[174],"CONCLUSIONS:":[175],"Rational":[176],"targeting":[177,251],"offers":[182],"unique":[184],"potent":[186,202],"clinical":[187],"opportunity.":[188],"In":[189],"vitro":[190],"analyses":[191],"revealed":[192],"kinase":[197],"imatinib,":[200],"induction":[203],"apoptosis.":[207],"Biochemical":[208],"studies":[209],"identified":[210],"changes":[211],"molecules":[214],"regulating":[215],"survival":[218],"responses,":[219],"which":[220],"may":[221],"serve":[222],"as":[223],"mediators":[224],"and/or":[225],"biomarkers":[226],"vivo":[229],"treatment":[230],"efficacy.":[231],"Pathways":[232],"provide":[237],"model":[239],"understanding":[241],"components":[242],"effective":[244],"death":[247],"insights":[249],"into":[250],"resistance":[253],"mechanisms.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}